StockData
Microbot Medical Inc. logo

Microbot Medical Inc. (MBOT) stock

MBOTNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 8/30
$0.69+0.04 (+6.92%)

Close on Nov 17, 2026Market cap $46.28MP/E –Yield –

Microbot Medical r&d expenses

Research and development expenses are spending on new products and technology.

Microbot Medical's R&D Expenses for the twelve months ending Jun 30, 2026 was $5.87M, down 22.9% year over year. For fiscal 2025 it was $6.28M, down 5.2% from the year before. The highest annual figure on record is $21.50M in fiscal 2014.

Annual r&d expenses

PeriodPeriod endValueChange
FY2025Dec 31, 2025$6.28M-5.2%
FY2024Dec 31, 2024$6.63M+15.8%
FY2023Dec 31, 2023$5.72M-26.0%
FY2022Dec 31, 2022$7.74M+25.7%
FY2021Dec 31, 2021$6.15M+81.2%
FY2020Dec 31, 2020$3.40M+11.4%
FY2019Dec 31, 2019$3.05M+21.2%
FY2018Dec 31, 2018$2.52M+128.6%
FY2017Dec 31, 2017$1.10M–
FY2016Dec 31, 2016-$901.00K–
FY2015Dec 31, 2015-$823.00K-103.8%
FY2014Dec 31, 2014$21.50M+11.0%
FY2013Dec 31, 2013$19.37M+31.9%
FY2012Dec 31, 2012$14.68M-26.4%
FY2011Dec 31, 2011$19.94M-5.1%
FY2010Dec 31, 2010$21.02M+5.5%
FY2009Dec 31, 2009$19.93M–

Quarterly r&d expenses

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$1.86M-11.8%
Q1 FY2026Mar 31, 2026$1.29M-11.4%
Q4 FY2025Dec 31, 2025$1.54M-22.3%
Q3 FY2025Sep 30, 2025$1.17M-43.2%
Q2 FY2025Jun 30, 2025$2.11M+49.0%
Q1 FY2025Mar 31, 2025$1.46M+24.8%
Q4 FY2024Dec 31, 2024$1.98M+75.6%
Q3 FY2024Sep 30, 2024$2.06M+27.8%
Q2 FY2024Jun 30, 2024$1.42M+3.8%
Q1 FY2024Mar 31, 2024$1.17M-27.7%
Q4 FY2023Dec 31, 2023$1.13M-48.5%
Q3 FY2023Sep 30, 2023$1.61M-5.5%
Q2 FY2023Jun 30, 2023$1.37M-39.5%
Q1 FY2023Mar 31, 2023$1.62M+16.4%
Q2 FY2022Jun 30, 2022$2.19M+57.9%
Q1 FY2022Mar 31, 2022$1.71M+52.5%
Q4 FY2021Dec 31, 2021$2.26M+125.8%
Q3 FY2021Sep 30, 2021$1.39M+33.9%
Q2 FY2021Jun 30, 2021$1.39M+107.6%
Q1 FY2021Mar 31, 2021$1.12M+61.9%
Q4 FY2020Dec 31, 2020$999.00K+18.8%
Q3 FY2020Sep 30, 2020$1.04M+23.0%
Q2 FY2020Jun 30, 2020$669.00K-9.7%
Q1 FY2020Mar 31, 2020$691.00K+17.7%
Q4 FY2019Dec 31, 2019$841.00K+29.6%
Q3 FY2019Sep 30, 2019$843.00K+35.3%
Q2 FY2019Jun 30, 2019$741.00K-0.8%
Q1 FY2019Mar 31, 2019$587.00K+18.3%
Q4 FY2018Dec 31, 2018$649.00K+224.5%
Q3 FY2018Sep 30, 2018$623.00K+83.8%
Q2 FY2018Jun 30, 2018$747.00K+98.1%
Q1 FY2018Mar 31, 2018$496.00K+169.6%
Q4 FY2017Dec 31, 2017$200.00K–
Q3 FY2017Sep 30, 2017$339.00K–
Q2 FY2017Jun 30, 2017$377.00K–
Q1 FY2017Mar 31, 2017$184.00K–
Q3 FY2016Sep 30, 2016-$340.00K–
Q2 FY2016Jun 30, 2016-$44.00K–

More Microbot Medical figures

See a number that looks wrong?